FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

33682411000001105: Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
102535101000001110 Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
102535201000001115 Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Dapagliflozin propanediol monohydrate true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Is a Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has AMP Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Saxagliptin hydrochloride false Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Dapagliflozin propanediol monohydrate false Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dapagliflozin false Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance Dapagliflozin true Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Saxagliptin hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start